Geneos Therapeutics Company

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Total Funding: 39500000
Headquarters: Plymouth Meeting, Pennsylvania, United States
Funding Status: Early Stage Venture
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Last Funding Type: Series A
Last Funding Date: 2022-03-24
Investors Number: 5
Founded Date: 2016-08-01
Industry: DNA